Limitations, agreements, and source contact

CT Antigen TCR-Engineered T Cells for Myeloma · Source last updated 2019-01-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

clinicaltrials@adaptimmune.com

organization

Adaptimmune

title

Clinical Trials Management

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice